- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07634861
Evaluating a Text-Prompt AI Assistant for Chest CT Scans (AI-REPORT Study) (AI-REPORT)
An Evaluation Study of a Text-Based Chest CT-Assisted Diagnostic System: A Two-stage, Multicenter, Multireader Multicase (MRMC), Self-Crossover Controlled Trial
Visão geral do estudo
Status
Condições
Descrição detalhada
This study investigates whether an artificial intelligence (AI) system that drafts preliminary radiology reports can help experienced chest CT radiologists work faster while maintaining or improving report quality. The trial is conducted in two sequential phases. The first phase uses a set of complex, real-world historical cases. Radiologists interpret these cases both with and without the help of the AI-generated draft (AI-report) in a controlled, crossover study design. The second phase is a prospective, real-world deployment where the same AI-report system is integrated into the clinical workflow of participating radiologists as they interpret new, incoming chest CT scans in real time. We measure the time it takes to complete reports and, through blinded evaluations by other senior doctors, assess the quality of the final reports created with and without AI assistance. The goal is to determine if this AI tool can make radiologists' work more efficient and support high-quality patient care in actual practice.
1. Detailed Description
1.1 Study Design
This is a two-phase, multicenter, multireader, multicase (MRMC) study designed to evaluate the real-world clinical utility of an AI report generation system (AI-report).
- Stage 1 (controlled crossover evaluation): This stage employs a retrospective, randomized, two-period crossover design. A curated set of complex historical chest CT cases, previously discussed in multidisciplinary team (MDT) meetings, is used. Each participating radiologist acts as their own control, interpreting the same cases both with and without the AI draft under controlled conditions.
- Stage 2 (prospective real-world deployment): This stage is a prospective, observational study. The validated AI-report system is deployed into the live clinical workflow of the participating radiologists. They use the system in real-time as they interpret new, consecutive chest CT scans from their clinical duties, allowing for evaluation in an authentic clinical environment.
1.2 Objectives
- Primary objectives: To evaluate the impact of the AI-report system on 1) radiologist efficiency (interpretation time) and 2) the clinical quality of finalized reports, assessed in both a controlled retrospective setting (Phase 1) and a prospective real-world setting (Phase 2).
- Secondary objectives: To assess the nature and clinical significance of edits made to AI drafts, and to evaluate system usability and integration into the routine reporting workflow.
1.3 Study Population
- Radiologist Readers: Board-certified radiologists with ≥ 3 years of independent thoracic imaging practice.
- Blinded Evaluators: Eleven senior clinicians from the original MDT panels that contributed the Phase 1 cases, responsible for blinded quality assessment.
1.4 Intervention
The intervention is the provision of a fully AI-generated draft radiology report (AI-report). In Phase 1, this is provided within a controlled reading platform for historical cases. In Phase 2, the system is integrated into the clinical Picture Archiving and Communication System (PACS)/Radiology Information System (RIS) to generate drafts for prospective, real-time cases.
2. Study Procedures
Phase 1 (Retrospective Crossover): The 400 historical MDT cases are used. The study involves two reading rounds with a washout period. In each round, radiologists interpret a set of cases, with the AI condition (draft provided or not) randomized and crossed over between rounds. Interpretation time is recorded, and all finalized reports are collected for blinded pairwise comparison by the evaluator panel.
Phase 2 (Prospective Deployment): Following Phase 1, the AI-report system is activated in the clinical environment for participating radiologists. During a defined prospective observation period, the system generates drafts for eligible new chest CT scans. Radiologists use these drafts in their daily work. Reporting time and the AI drafts alongside the finalized human-edited reports are collected for analysis. Report quality in this phase is assessed longitudinally and through sampling.
3. Outcome Measures
3.1 Primary Outcomes:
Efficiency: Change in median interpretation time per case with vs. without AI-report assistance (Phase 1) and the distribution of reporting times during real-world use (Phase 2).
Quality: Superiority score from blinded paired comparisons of AI-assisted vs. unassisted reports (Phase 1). Qualitative and quantitative assessment of report adequacy in the prospective cohort (Phase 2).
3.2 Secondary Outcomes:
Clinical significance of radiologist modifications to AI drafts (5-point scale).
System usability and workflow integration scores from post-study surveys.
4. Statistical Analysis
Analysis will account for the MRMC design in Phase 1 using hierarchical models. Phase 2 data will be analyzed using descriptive statistics and statistical process control methods where appropriate. The two phases will be analyzed separately to provide insights into efficacy (Phase 1) and effectiveness (Phase 2).
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Xiaodan Ye, MD, PhD
- Número de telefone: +86-13761459998
- E-mail: yuanyxd@163.com
Estude backup de contato
- Nome: Weiqiu Jin, BEng, BA, MD
- E-mail: jinwqzsh@fudan.edu.cn
Locais de estudo
-
-
-
Shanghai, China
- Recrutamento
- Department of Radiology, Zhongshan Hospital, Fudan University
-
Investigador principal:
- Mengsu Zeng, MD, PhD
-
Contato:
- Xiaodan Ye, MD, PhD
- Número de telefone: +86-13761459998
- E-mail: yuanyxd@163.com
-
Contato:
- Weiqiu Jin, BEng, BA, MD
- E-mail: jinwqzsh@fudan.edu.cn
-
Shanghai, China
- Recrutamento
- United Imaging Intelligence, Shanghai
-
Contato:
- Dijia Wu, PhD
- Número de telefone: 86-21-67076888
- E-mail: dijia.wu@uii-ai.com
-
Contato:
- Jiayu Wang, MS
- E-mail: jiayu.wang@uii-ai.com
-
Investigador principal:
- Dinggang Shen, PhD
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Active board certification and ongoing routine clinical practice as an attending radiologist
- Independent institutional authority for chest CT image interpretation and final official diagnostic report issuance
- A minimum of three years of post-certification clinical experience in specialized thoracic imaging
- Legal and cognitive competence for study participation, with voluntary provision of written informed consent after full understanding of study purpose, procedures, risks and benefits
Exclusion Criteria:
- Direct participation in the development, training or validation of the trial's evaluated AI system
- Ongoing participation in concurrent studies with potential risks of interpretation bias, cognitive fatigue or study procedure interference (investigator-assessed)
- Any actual or perceived conflict of interest related to the evaluated AI system or its developers that may compromise objectivity in image interpretation and diagnostic reporting
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Diagnóstico
- Alocação: Randomizado
- Modelo Intervencional: Atribuição cruzada
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: AI-Assisted Reporting Arm
This arm involves board-certified radiologists interpreting chest CT cases using the AI system, which generates a preliminary report draft.
In Phase 1 (retrospective crossover), each radiologist interprets the same set of historical cases twice: once with the AI-generated draft and once without, with order randomized and a washout period.
In Phase 2 (prospective real-world deployment), radiologists use AI drafts for consecutive new chest CT scans in routine practice.
The intervention is the provision of the AI-generated report draft; no other changes to standard workflow are introduced.
|
A clinical decision support software generates a preliminary report draft for chest CT examinations.
Board-certified radiologists then finalize the AI draft.
|
|
Comparador Ativo: Standard Reporting
This arm involves board-certified radiologists interpreting chest CT cases without AI assistance, following standard workflow procedures.
In Phase 1 (retrospective crossover), radiologists interpret the same set of historical cases without the AI-generated draft (order randomized with a washout period).
In Phase 2 (prospective real-world deployment), this arm represents routine clinical practice where no AI drafts are provided for new chest CT scans.
The control condition is standard reporting without AI assistance.
|
Standard chest CT reporting procedure without AI assistance.
Board-certified radiologists independently interpret chest CT examinations and generate final reports following standard clinical workflow without preliminary AI-generated drafts.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Subjective report quality evaluation based on diagnostic requirements and clinical relevance
Prazo: CT reports will be distributed for external clinician scoring once all required data are available (typically ≤ 2 weeks post Primary Completion Date); the final aggregated analysis will be completed within 4 weeks post Primary Completion Date.
|
Quality is blindly assessed by independent clinicians using pairwise comparisons among three report types: AI-generated raw reports, human-only reports, and human-AI collaborative reports.
Superior reports score 1 point, ties score 0.5.
|
CT reports will be distributed for external clinician scoring once all required data are available (typically ≤ 2 weeks post Primary Completion Date); the final aggregated analysis will be completed within 4 weeks post Primary Completion Date.
|
|
Significance of radiologist modifications to AI-generated reports
Prazo: CT reports will be distributed for external clinician scoring once all required data are available (typically ≤ 2 weeks post Primary Completion Date); the final aggregated analysis will be completed within 4 weeks post Primary Completion Date.
|
Using a 5-point ordinal scale, independent external clinicians rate the clinical significance of edits made to AI reports.
Level 1 denotes minimal changes; Level 5 indicates critical corrections preventing inappropriate/delayed management.
Intermediate levels (2-4) represent minor adjustments, beneficial optimizations, and significant refinements impacting diagnostic clarity or treatment selection.
|
CT reports will be distributed for external clinician scoring once all required data are available (typically ≤ 2 weeks post Primary Completion Date); the final aggregated analysis will be completed within 4 weeks post Primary Completion Date.
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Cadeira de estudo: Mengsu Zeng, MD, PhD, Department of Radiology, Zhongshan Hospital, Fudan University
- Diretor de estudo: Dinggang Shen, PhD, United Imaging Intelligence, Shanghai
- Diretor de estudo: Jianying Gu, MD, PhD, Department of Radiology, Zhongshan Hospital, Fudan University
- Diretor de estudo: Dijia Wu, PhD, United Imaging Intelligence, Shanghai
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- B2025-151
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .